These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31021825)

  • 1. Natural and synthetic retinoids in preclinical colorectal cancer models.
    Abdel-Samad R; Aouad P; Darwiche N
    Anticancer Drugs; 2019 Aug; 30(7):e0802. PubMed ID: 31021825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products for treating colorectal cancer: A mechanistic review.
    Huang XM; Yang ZJ; Xie Q; Zhang ZK; Zhang H; Ma JY
    Biomed Pharmacother; 2019 Sep; 117():109142. PubMed ID: 31238258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural compounds and combination therapy in colorectal cancer treatment.
    Rejhová A; Opattová A; Čumová A; Slíva D; Vodička P
    Eur J Med Chem; 2018 Jan; 144():582-594. PubMed ID: 29289883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of natural products in colorectal cancer drug discovery.
    Miura K; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kakugawa Y; Kawai M; Uchimi K; Aizawa H; Ohnuma S; Kajiwara T; Sakurai H; Fujiya T
    Expert Opin Drug Discov; 2015 Apr; 10(4):411-26. PubMed ID: 25724579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential of retinoids for combination therapy of lung cancer: Updates and future directions.
    Tripathi SK; Pandey K; Panda M; Spinella MJ; Rengasamy KR; Biswal BK
    Pharmacol Res; 2019 Sep; 147():104331. PubMed ID: 31254665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
    Freemantle SJ; Spinella MJ; Dmitrovsky E
    Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Challenges of Synthetic Retinoid Formulations in Cancer.
    Assi S; Hajj HE; Hayar B; Pisano C; Saad W; Darwiche N
    Curr Drug Deliv; 2023; 20(9):1314-1326. PubMed ID: 35950256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental basis of cancer combination chemotherapy with retinoids, cytokines, 1,25-dihydroxyvitamin D3, and analogs.
    Bollag W
    J Cell Biochem; 1994 Dec; 56(4):427-35. PubMed ID: 7890801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
    Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
    Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoids and ovarian cancer.
    Zhang D; Holmes WF; Wu S; Soprano DR; Soprano KJ
    J Cell Physiol; 2000 Oct; 185(1):1-20. PubMed ID: 10942515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids, apoptosis and cancer.
    Simoni D; Tolomeo M
    Curr Pharm Des; 2001 Nov; 7(17):1823-37. PubMed ID: 11562311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms.
    Wagner J; Kline CL; Zhou L; Khazak V; El-Deiry WS
    J Exp Clin Cancer Res; 2018 Jan; 37(1):11. PubMed ID: 29357916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on the molecular mechanisms, the therapeutic treatment including the potential of herbs and natural products, and target prediction of obesity-associated colorectal cancer.
    Yang H; Yue GGL; Leung PC; Wong CK; Lau CBS
    Pharmacol Res; 2022 Jan; 175():106031. PubMed ID: 34896542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective retinoids and rexinoids in cancer therapy and chemoprevention.
    Zusi FC; Lorenzi MV; Vivat-Hannah V
    Drug Discov Today; 2002 Dec; 7(23):1165-74. PubMed ID: 12547017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoids as preventive and therapeutic anticancer agents (Part I).
    Lippman SM; Kessler JF; Meyskens FL
    Cancer Treat Rep; 1987 Apr; 71(4):391-405. PubMed ID: 3548957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoids in combination therapies for the treatment of cancer: mechanisms and perspectives.
    Ortiz MA; Bayon Y; Lopez-Hernandez FJ; Piedrafita FJ
    Drug Resist Updat; 2002; 5(3-4):162-75. PubMed ID: 12237083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoids as cancer-preventive agents.
    Sankaranarayanan R; Mathew B
    IARC Sci Publ; 1996; (139):47-59. PubMed ID: 8923019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.
    Zhang WJ; Li Y; Wei MN; Chen Y; Qiu JG; Jiang QW; Yang Y; Zheng DW; Qin WM; Huang JR; Wang K; Zhang WJ; Wang YJ; Yang DH; Chen ZS; Shi Z
    Cancer Lett; 2017 Feb; 386():100-109. PubMed ID: 27864115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural and synthetic retinoids in prostate cancer.
    Pasquali D; Rossi V; Bellastella G; Bellastella A; Sinisi AA
    Curr Pharm Des; 2006; 12(15):1923-9. PubMed ID: 16724957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.